XML 32 R5.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Share Capital (Note 14)
Contributed Surplus
Accumulated Other Comprehensive Income (Loss)
Deficit
Total
Balance at beginning of period at Dec. 31, 2016 $ 4,666.2 $ 41.6 $ (224.5) $ (336.8) $ 4,146.5
Net income       194.7 194.7
Other comprehensive (loss) income     118.0   118.0
Total comprehensive income         312.7
Exercise of stock options 14.1 (4.0)     10.1
Exercise of warrants 382.9 (26.5)     356.4
Share-based payments   5.6     5.6
Vesting of restricted share units 2.5 (2.5)      
Dividend reinvestment plan 42.1       42.1
Dividends declared       (167.9) (167.9)
Balance at end of period at Dec. 31, 2017 5,107.8 14.2 (106.5) (310.0) 4,705.5
Impact on adoption of IFRS 9 (Note 2)     (27.1) 27.1  
Restated balance at January 1, 2018 5,107.8 14.2 (133.6) (282.9) 4,705.5
Net income       139.0 139.0
Other comprehensive (loss) income     (86.7)   (86.7)
Total comprehensive income         52.3
Exercise of stock options 5.5 (1.3)     4.2
Share-based payments   6.0     6.0
Vesting of restricted share units 3.3 (3.3)      
Dividend reinvestment plan 41.7       41.7
Dividends declared       (177.8) (177.8)
Balance at end of period at Dec. 31, 2018 $ 5,158.3 $ 15.6 $ (220.3) $ (321.7) $ 4,631.9